
Treatment-Resistant Depression: How SPRAVATO® Is Thought to Work and What Research Shows
We explain how SPRAVATO® may work for treatment-resistant depression, what research can tell you, and why treatment happens in a supervised clinic.

We explain how SPRAVATO® may work for treatment-resistant depression, what research can tell you, and why treatment happens in a supervised clinic.

We explain how treatment-resistant depression is assessed, what your treatment history can reveal, and which questions can guide your next care discussion.

We explain SPRAVATO® eligibility, treatment monitoring, insurance questions, and how to begin a conversation about treatment-resistant depression.

We explain why depressive and manic episodes can be missed, which signs of bipolar disorder deserve attention, and what to bring to an assessment.

We explain how worry, tension, avoidance, and sleep changes can guide a conversation about stress, anxiety, and whether a psychiatric evaluation may help.

We explain less-recognized PTSD symptoms, from avoidance and constant alertness to emotional numbness, and what you can share during an evaluation.

We explore what a psychiatric evaluation can reveal about persistent insomnia, from mood and stress to medications, routines, and medical concerns.

We explain how panic attacks differ from panic disorder, when physical symptoms need urgent care, and what to share during an evaluation.

We explain psychiatric medication management, from your first visit to follow-ups, side effect conversations, monitoring, and decisions you help shape.